119 related articles for article (PubMed ID: 1714087)
1. Immunogenicity of Trypanosoma cruzi cysteine proteinase.
Arnholdt AC; Scharfstein J
Res Immunol; 1991 Feb; 142(2):146-51. PubMed ID: 1714087
[No Abstract] [Full Text] [Related]
2. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
5. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
Xu BX; Powell MR
J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
[TBL] [Abstract][Full Text] [Related]
7. [Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease].
Alberti Amador E; Fachado Carvajales A; Montalvo AM; Izquierdo Pérez LA; Fonte Galindo L
Rev Cubana Med Trop; 1998; 50(1):75-81. PubMed ID: 9842273
[TBL] [Abstract][Full Text] [Related]
8. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains.
Martínez J; Campetella O; Frasch AC; Cazzulo JJ
Immunol Lett; 1993 Feb; 35(2):191-6. PubMed ID: 7685319
[TBL] [Abstract][Full Text] [Related]
9. Human Chagas' disease: evolution of the antibody response and recognition of antigens of Trypanosoma cruzi.
Araujo FG; Israelski DM; de Titto EH
Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():522-6. PubMed ID: 3151007
[No Abstract] [Full Text] [Related]
10. Lytic antibodies elicited by Trypanosoma cruzi infection recognize epitopes present on both bloodstream trypomastigote and epimastigote forms of parasite.
Takehara HA; Cardoso DF; da Silva AM; Mota I
Rev Inst Med Trop Sao Paulo; 1988; 30(5):351-6. PubMed ID: 2471248
[No Abstract] [Full Text] [Related]
11. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.
Arnholdt AC; Piuvezam MR; Russo DM; Lima AP; Pedrosa RC; Reed SG; Scharfstein J
J Immunol; 1993 Sep; 151(6):3171-9. PubMed ID: 7690795
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
[TBL] [Abstract][Full Text] [Related]
13. Exoantigens from trypanosoma cruzi contain cruzipain.
Gruppi A; Cerbán FM; Vottero-Cima E
Acta Trop; 1997 Feb; 63(2-3):141-9. PubMed ID: 9088427
[TBL] [Abstract][Full Text] [Related]
14. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
15. Failure to find anti-component 5 antibodies in animals infected with Trypanosoma cruzi.
Santoro F; Afchain D; Capron A; Sadigursky M; Sherlock I
Trans R Soc Trop Med Hyg; 1987; 81(3):512. PubMed ID: 3120373
[No Abstract] [Full Text] [Related]
16. Carbohydrate immunity in American trypanosomiasis.
Travassos LR; Almeida IC
Springer Semin Immunopathol; 1993; 15(2-3):183-204. PubMed ID: 8256197
[No Abstract] [Full Text] [Related]
17. Antigens de Trypanosoma cruzi with clinical interest cloned and expressed in Escherichia coli.
Da Silveira ; Paranhos GS; Cotrim PC; Mortara RA; Camargo ME; Rassi A; Wanderley J; Corral R; Freilij HL; Grinstein S
Mem Inst Oswaldo Cruz; 1990; 85(4):507-11. PubMed ID: 2152208
[No Abstract] [Full Text] [Related]
18. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
[TBL] [Abstract][Full Text] [Related]
19. Prospects of defined proteins for vaccine development.
Frasch AC; Sánchez DO; Cazzulo JJ
Mem Inst Oswaldo Cruz; 1990; 85(4):523-9. PubMed ID: 2152211
[No Abstract] [Full Text] [Related]
20. [Antigens in Trypanosoma cruzi].
Búa JE; Bontempi EJ; Ruiz AM; Segura EL
Rev Argent Microbiol; 1990; 22(1):37-55. PubMed ID: 2125741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
